RCUS — Arcus Biosciences Share News
0.000.00%
Last trade - 00:00- $2.91bn
- $2.30bn
- $247.00m
U.S. STOCKS ON THE MOVE-CME, Lockheed Martin, Valero Energy
Arcus Biosciences tumbles on $250 mln share sale
Brief: Arcus Biosciences Announces Pricing Of $250 Million Public Offering Of Common Stock
Arcus Biosciences drops after starting stock offering
US RESEARCH ROUNDUP-Adobe, Domino's Pizza, Goldman Sachs
U.S. STOCKS ON THE MOVE-Robinhood, Hartford Insurance, SpaceX
U.S. STOCKS ON THE MOVE-SpaceX, Union Pacific, IBM
U.S. STOCKS ON THE MOVE-IBM, Huntington Bancshares, Meritage Homes
U.S. STOCKS ON THE MOVE-Intel, Axon Enterprise, J.B. Hunt
Arcus gains after TD Cowen starts coverage with 'buy' rating
Arcus Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Arcus Biosciences Q2 revenue falls sharply on lower license income
Brief: Arcus Biosciences Q2 Pretax Profit USD -91 Million
Arcus Biosciences Inc expected to post a loss of 90 cents a share - Earnings Preview
Brief: Arcus Biosciences And Summit Therapeutics Enter Into Clinical Trial Collaboration
Brief: Arcus Biosciences And Summit Therapeutics Enter Into Clinical Trial Collaboration
Brief: Arcus Biosciences Announces Clinical Supply Agreement With Aveo Oncology
Arcus Biosciences Q1 revenue falls on lower development services
Brief: Arcus Biosciences Q1 Net Income USD -128 Million